Ivy Rx review

Ivy Rx brings prescription weight care, longevity treatments and supplements into one storefront. Its compounded GLP-1 page lists semaglutide and tirzepatide injections, while a separate microdose page offers either ingredient at a lower starting reference. The broader catalog includes NAD+, sermorelin, glutathione and B12 preparations. That range makes it especially important to identify the actual product before comparing services. A prescription injection, a nasal spray and a capsule sold as a supplement carry different questions about evidence and oversight. A shared checkout brand does not establish that every item has the same clinical support or regulatory status.

Start with the plan checklist and ask for the proposed medicine, preparation, quantity and full payment schedule. The GLP-1 headline specifies four doses per month, but it does not settle which ingredient or commitment earns the advertised starting price. The microdose listing has its own reference. Neither figure should become a complete recurring bill without the selected agreement. Ivy Rx also advertises the same price at every dose. Confirm what that means for the chosen program, switching ingredients and any additional services. A reassuring pricing phrase does not fill in missing supply or renewal details.

The longevity listings need equally careful reading. NAD+ is offered as an injection and a separate nasal spray, with different descriptions of supply. The injection page says use varies; the spray specifies thirty sprays. Neither statement establishes a calendar-month treatment course. Sermorelin also appears as an injection, but its homepage and dedicated product page show different starting figures. Keep that discrepancy visible until the applicable quote is supplied. The NAD+ guide and sermorelin guide help frame questions about preparation and evidence. They cannot establish benefits from a particular prescription or replace a clinician's assessment.

Glutathione, methylcobalamin B12 and MIC+B12 injections add more choices, rather than proving that extras are needed alongside weight treatment. MIC+B12 names methionine, inositol and choline with B12 and gives a ten-dose supply reference. Ten doses are not automatically ten days or a month. The glutathione guide provides background for a discussion with the prescriber. Ask what a proposed addition addresses, how its evidence applies to the actual preparation and whether it adds a separate charge. Do not assume a broad anti-aging goal is a diagnosis or that several products work better together.

One catalog item warrants particular caution: BPC-157 capsules are marketed under supplements with recovery and tissue-repair claims. FDA's compounding risk page describes limited safety information and potential immune-response and peptide-impurity concerns. Its BPC-157 entry appears under withdrawn bulk-substance nominations; that placement is not an approval. The capsule listing does not establish human recovery benefits, acceptable supplement status or a safe treatment course. A separate Gut Peptide Complex describes a blend without establishing the individual peptide identities in the material presented. Do not infer its contents from the product name or treat either listing as a routine clinical recommendation.

The quality section needs to be read as provider marketing. It describes preparation in a state-licensed pharmacy and testing in registered labs, accompanied by passed-test badges. The reviewed pages do not identify the dispensing facility assigned to a prescription or provide a lot-specific certificate. A capsule page even repeats wording about an irritation-free injection. That template wording is not useful evidence about a capsule. Ask for the actual pharmacy, the preparation and relevant quality documentation. FDA registration is not product approval, and a lab claim cannot establish that every product in a mixed prescription-and-supplement catalog has been validated by an outside organization.

For prescription care, Ivy Rx describes an online medical-history review by a licensed doctor or nurse practitioner. Product pages advertise same-day review, while the telehealth FAQ gives a twenty-four-hour review expectation. These are published service descriptions, not guaranteed approval or a promise of a live video appointment. An advisory board is listed separately and should not be mistaken for the clinician assigned to treatment. Ask who will prescribe, which professional entity provides care and how follow-up questions are handled. The actual prescriber's current credentials and authority for the patient's location still require confirmation before relying on that relationship.

The GLP-1 page says lab work is not needed. That statement does not establish whether additional evaluation could be necessary for a particular person or what future testing would cost. It also does not replace an explanation of ongoing monitoring. The portal is described as a way to message providers, and the contact page lists customer-service hours. Customer-service availability should not be presented as continuous clinician coverage. Ask about refill review, message turnaround and escalation when a concern cannot wait. The care-fee guide helps separate included contact from separately billed clinical services without assuming an answer for this program.

Delivery involves more than the advertised carrier service. The shipping FAQ describes three to five business days of pharmacy processing, potentially seven to ten during high demand, followed by shipping. A different overview says delivery usually takes three to five business days. Request a current estimate that distinguishes approval, preparation, dispatch and arrival. Free shipping through partner pharmacies is described, but the partner's identity and the selected destination still matter. General nationwide marketing is not confirmation that every product is available in every state. A Florida contact address identifies an office, not the location where a prescription will be compounded.

Cancellation language also needs a specific plan attached to it. The main terms describe one- or three-month prepaid subscriptions followed by monthly renewal. They instruct customers to contact support before the period ends, while a later billing section allows portal cancellation or modification. Public marketing says there are no long-term contracts or cancellation fees. These statements do not establish a precise processing cutoff or a refund for an order already underway. Use the billing comparison tool to record the selected dates and charges. Obtain written confirmation of when future billing stops and what happens to medication already being prepared.

The refund descriptions differ. Main-site terms allow a request within fifteen days of an order, subject to specified email requirements and review. That is not a fifteen-day satisfaction guarantee. The separate refund page says products cannot be returned, and the general FAQ says transactions are final with no reimbursements. Ask which provision applies before payment, including the handling of errors or damaged deliveries. Financing options mentioned in the help center depend on the order and provider availability. A smaller installment does not change the underlying purchase obligation or establish that medication and care can be refunded after cancellation.

Privacy deserves its own question before submitting health information. The privacy notice states that Ivy Rx is not subject to HIPAA and that information submitted through its website or service is not HIPAA protected health information. A help article describes the website as HIPAA compliant. Those statements need their scopes explained, including who holds the clinical record. The consumer-health notice describes additional Nevada and Washington rights and limits. Compare the Strut Health review and DirectMeds review on the same prescription, care, pharmacy and contract questions. The breadth of Ivy Rx's menu is useful only when the selected arrangement is clear.